MonoSol Rx
Pharmaceutical ManufacturingUnited States11-50 Employees
MonoSol Rx has changed its name to Aquestive Therapeutics. Please visit us at our LinkedIn page here: https://www.linkedin.com/company/27134881/
Innovative Delivery Technologies Aquestive Therapeutics specializes in advanced drug delivery systems, which could interest companies seeking novel formulations or delivery platforms to enhance their product portfolio or improve patient compliance.
Recent Leadership Expansion The appointment of a new Chief Legal Officer and ongoing legal actions suggest active corporate growth and strategic restructuring, presenting opportunities to offer compliance solutions or legal advisory services aligned with their expansion efforts.
Clinical Advancement & Events Participation in major industry conferences and presentation of investigational products like Anaphylm indicates ongoing R&D investments, opening avenues for collaboration on clinical trials, research support, or medical communication services.
Financial Size & Scope With revenue between $50M and $100M and a relatively small workforce, Aquestive is likely seeking scalable, efficient solutions in manufacturing, supply chain, or technology integration to support its growth trajectory.
Legal & Compliance Focus Multiple recent lawsuits highlight a focus on legal compliance and risk management, offering potential benefits from specialized legal, regulatory, or compliance consulting services tailored to pharmaceutical manufacturing companies.
MonoSol Rx uses 8 technology products and services including Amazon Advertising, MySQL, Veeva Vault, and more. Explore MonoSol Rx's tech stack below.
| MonoSol Rx Email Formats | Percentage |
| FLast@monosolrx.com | 79% |
| First.Last@monosolrx.com | 9% |
| FirstL@monosolrx.com | 3% |
| Last@monosolrx.com | 3% |
| First@monosolrx.com | 3% |
| FirstLast@monosolrx.com | 2% |
| F.Last@monosolrx.com | 1% |
| FLast@aquestive.com | 89% |
| Last@aquestive.com | 8% |
| First.Last@aquestive.com | 2% |
| First@aquestive.com | 1% |
Pharmaceutical ManufacturingUnited States11-50 Employees
MonoSol Rx has changed its name to Aquestive Therapeutics. Please visit us at our LinkedIn page here: https://www.linkedin.com/company/27134881/
MonoSol Rx's revenue is estimated to be in the range of $50M$100M
MonoSol Rx's revenue is estimated to be in the range of $50M$100M